Home / News / Clinical Trials
Clinical Trials
Pembrolizumab-Chemo Combo Enhances Advanced Endometrial Cancer Care
Pembrolizumab plus chemotherapy is changing first-line care for advanced endometrial cancer, with NRG GY018 showing major progression-free survival gains across MMR status.
May 29, 2026
All FDA Approvals
All Cancer Types Endometrial Cancer
All Therapeutic Approaches Chemotherapy Immunotherapy Targeted Therapy
North American Enrollment in Clinical Trials
Clinical Trials

North American Enrollment in Clinical Trials

Dr. Ming-Hei Tai April 15, 2026

What are you looking for?

Popular Searches

Oncology Practice Management Navigation